EMD-26513

Single-particle
3.1 Å
EMD-26513
3D View Gallery
Deposition: 26/03/2022
Map released: 11/05/2022
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-26513
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7uhf summary report (pdf.gz) Map and 7uhf FULL report (pdf.gz)
EMICSS annotations (xml)

Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom resolution

EMD-26513

Single-particle
3.1 Å
EMD-26513
3D View Gallery
Deposition: 26/03/2022
Map released: 11/05/2022
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Homo sapiens
Sample: Cav1.3
Fitted models: 7uhf (Avg. Q-score: 0.425)

Deposition Authors: Gao S , Yao X , Yan N
Structural basis for pore blockade of human voltage-gated calcium channel Ca v 1.3 by motion sickness drug cinnarizine.
Yao X , Gao S , Yan N
(2022) Cell Res , 32 , 946 - 948
PUBMED: 35477996
DOI: doi:10.1038/s41422-022-00663-5
ISSN: 1001-0602